FP7H2020HORIZON
Fundacion Para la Investigacion Medica Aplicada Fima
- Country
- ESSpain
- Defence projects
- 0
- Projects, all programmes
- 41
- As coordinator
- 20
- EU contribution (CORDIS)
- EUR 17,346,139
- Active
- 2008 to 2024
Projects
41 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| TLSaRNAArtificial induction of tertiary lymphoid structures (TLS) in tumors using intratumoral mRNAs to evaluate its synergy with immune checkpoint inhibitors | HORIZON | 2024 | Coordinator | EUR 181,153 |
| SPACETIMESPatial Analysis of Cancer Evolution in the Tumour Immune MicroEnvironment | HORIZON | 2024 | Participant | EUR 619,650 |
| RIPECROPRNA-based cancer ImmunotheraPeutics to Enhance CROssPrimming | HORIZON | 2024 | Coordinator | EUR 2,411,500 |
| DRIMMSDissecting the role of the immune microenvironment in the onset of myelodysplastic syndromes | HORIZON | 2023 | Coordinator | EUR 181,153 |
| NONCO-MICROTISExploiting single cell long non-coding RNA biology to target therapy-induced senescence in lung cancer | HORIZON | 2022 | Coordinator | EUR 181,153 |
| DESTINATIONAI-enabled RNA nanotechnology DElivery SysTem for INformATION transfer into cells. | H2020 | 2021 | Participant | EUR 509,184 |
| CRUCIALMiCrovasculaR rarefaction in vascUlar Cognitive Impairement and heArt faiLure | H2020 | 2020 | Participant | EUR 459,505 |
| cONCReTEDevelOpmeNt of Cancer RNA TherapEutics | H2020 | 2020 | Participant | EUR 110,400 |
| AND-PDCOMORBIDITY MECHANISMS OF ANXIETY AND PARKINSON’S DISEASE | H2020 | 2020 | Participant | EUR 130,625 |
| LINKERElucidating transcriptional rewiring on hematological malignancies via computational methods | H2020 | 2020 | Coordinator | EUR 172,932 |
| SyLeNCeSynapses between Leukaemia and its Neighbouring Cells | H2020 | 2020 | Coordinator | EUR 160,932 |
| CINKAdvancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers | H2020 | 2018 | Coordinator | EUR 158,122 |
| NonChroRepInvestigating the role of the long noncoding transcriptome in chromatin replication | H2020 | 2018 | Coordinator | EUR 2,000,000 |
| Tumor-Treg-TargetingTraining Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours | H2020 | 2018 | Participant | EUR 247,873 |
| EN_ACTI2NGEuropean Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry | H2020 | 2017 | Participant | EUR 247,873 |
| TARGEPILIVERCharacterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. | H2020 | 2015 | Coordinator | EUR 170,122 |
| PROCROPProfessional cross-priming for ovary and prostate cancer | H2020 | 2015 | Coordinator | EUR 1,190,000 |
| REPROPARKNew experimental therapeutic approaches for Parkinson’s disease by direct DA neuronal reprogramming | FP7 | 2014 | Participant | EUR 420,500 |
| INTEREXTInterspecies endotheliarization for organ xenotransplantation | H2020 | 2014 | Coordinator | EUR 223,002 |
| FIBRO-TARGETSTargeting cardiac fibrosis for heart failure treatment | FP7 | 2013 | Participant | EUR 600,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.